Old Web
English
Sign In
Acemap
>
authorDetail
>
Sourav Santra
Sourav Santra
Biogen Idec
Multiple sclerosis
Natalizumab
Medicine
Internal medicine
Physical therapy
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study.
2020
BMJ Open
Helmut Butzkueven
Stephanie Licata
Douglas Jeffery
Douglas L. Arnold
Massimo Filippi
Jeroen J. G. Geurts
Sourav Santra
Nolan Campbell
Pei-Ran Ho
Show All
Source
Cite
Save
Citations (5)
Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE
2019
BMC Neurology
Jai Perumal
Robert J. Fox
Roumen Balabanov
Laura J. Balcer
Steven L. Galetta
Shavy Makh
Sourav Santra
Christophe Hotermans
Lily Lee
Show All
Source
Cite
Save
Citations (18)
Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis
2018
CNS Drugs
Mark Gudesblatt
Karl Wissemann
Myassar Zarif
Barbara Bumstead
Lori Fafard
Jeffrey Wilken
Karen Blitz
Marijean Buhse
Sourav Santra
Christophe Hotermans
Lily Lee
Show All
Source
Cite
Save
Citations (6)
1